Gunnar Boysen
Concepts (356)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Butadienes | 16 | 2022 | 47 | 4.060 |
Why?
| DNA Adducts | 15 | 2025 | 79 | 3.020 |
Why?
| Tandem Mass Spectrometry | 17 | 2019 | 227 | 2.710 |
Why?
| Epoxy Compounds | 12 | 2021 | 45 | 2.550 |
Why?
| Lung Neoplasms | 6 | 2024 | 602 | 2.420 |
Why?
| Carcinogens | 9 | 2022 | 197 | 1.990 |
Why?
| Chromatography, Liquid | 13 | 2020 | 225 | 1.920 |
Why?
| Hemoglobins | 8 | 2022 | 106 | 1.720 |
Why?
| Valine | 7 | 2019 | 57 | 1.590 |
Why?
| Benzeneacetamides | 2 | 2024 | 12 | 1.590 |
Why?
| Glutaminase | 2 | 2024 | 18 | 1.590 |
Why?
| Cytochrome P-450 CYP2E1 | 6 | 2017 | 110 | 1.540 |
Why?
| Glutathione | 7 | 2021 | 296 | 1.420 |
Why?
| DNA | 12 | 2025 | 543 | 1.380 |
Why?
| Guanine | 7 | 2018 | 40 | 1.210 |
Why?
| Microsomes, Liver | 12 | 2021 | 182 | 1.150 |
Why?
| Radiation Tolerance | 2 | 2019 | 83 | 1.100 |
Why?
| Biotin | 5 | 2014 | 46 | 1.090 |
Why?
| Thiadiazoles | 3 | 2024 | 18 | 1.000 |
Why?
| Chromatography, High Pressure Liquid | 12 | 2021 | 326 | 0.970 |
Why?
| Glutamine | 3 | 2024 | 169 | 0.840 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 7 | 2010 | 60 | 0.830 |
Why?
| Mutation | 8 | 2025 | 1292 | 0.800 |
Why?
| Cisplatin | 4 | 2024 | 275 | 0.730 |
Why?
| Metabolome | 2 | 2021 | 91 | 0.730 |
Why?
| Metabolomics | 1 | 2021 | 131 | 0.710 |
Why?
| Glutathione Transferase | 1 | 2020 | 174 | 0.700 |
Why?
| Mice | 22 | 2024 | 5658 | 0.690 |
Why?
| Busulfan | 1 | 2019 | 19 | 0.680 |
Why?
| Animals | 33 | 2024 | 13100 | 0.670 |
Why?
| Transplantation Conditioning | 1 | 2019 | 82 | 0.650 |
Why?
| Apoptosis | 1 | 2024 | 1092 | 0.640 |
Why?
| Humans | 51 | 2025 | 49929 | 0.640 |
Why?
| Lung | 2 | 2021 | 501 | 0.620 |
Why?
| Carnitine | 3 | 2014 | 61 | 0.610 |
Why?
| Enzyme Inhibitors | 3 | 2019 | 378 | 0.550 |
Why?
| Mitochondria, Liver | 1 | 2017 | 69 | 0.550 |
Why?
| Complex Mixtures | 2 | 2014 | 7 | 0.540 |
Why?
| Neoplasms | 3 | 2025 | 1234 | 0.530 |
Why?
| Warfarin | 5 | 2018 | 83 | 0.530 |
Why?
| Oxidative Stress | 3 | 2017 | 759 | 0.520 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2021 | 122 | 0.520 |
Why?
| Pyrrolidines | 3 | 2011 | 67 | 0.510 |
Why?
| Lymph Nodes | 1 | 2017 | 257 | 0.500 |
Why?
| Molecular Structure | 7 | 2020 | 293 | 0.500 |
Why?
| Deoxyguanosine | 3 | 2009 | 27 | 0.490 |
Why?
| Benzo(a)pyrene | 3 | 2003 | 12 | 0.480 |
Why?
| Valerates | 2 | 2011 | 35 | 0.470 |
Why?
| Carcinoma, Squamous Cell | 1 | 2017 | 330 | 0.460 |
Why?
| Alkanes | 1 | 2014 | 8 | 0.460 |
Why?
| Cell Line, Tumor | 5 | 2024 | 1388 | 0.450 |
Why?
| Mass Spectrometry | 7 | 2021 | 283 | 0.440 |
Why?
| Deficiency Diseases | 2 | 2012 | 13 | 0.440 |
Why?
| Cytochrome P-450 CYP3A | 3 | 2021 | 77 | 0.440 |
Why?
| Peptides | 3 | 2009 | 220 | 0.430 |
Why?
| Adenocarcinoma | 1 | 2017 | 402 | 0.430 |
Why?
| Environmental Pollutants | 1 | 2014 | 92 | 0.420 |
Why?
| Carcinogens, Environmental | 1 | 2012 | 22 | 0.420 |
Why?
| Occupational Exposure | 2 | 2011 | 112 | 0.410 |
Why?
| Biotinidase Deficiency | 1 | 2011 | 1 | 0.390 |
Why?
| Mutagenesis | 2 | 2009 | 59 | 0.390 |
Why?
| Egg White | 1 | 2011 | 6 | 0.390 |
Why?
| Diphenylamine | 2 | 2021 | 5 | 0.390 |
Why?
| Air Pollutants, Occupational | 1 | 2011 | 17 | 0.390 |
Why?
| Anticoagulants | 4 | 2018 | 254 | 0.390 |
Why?
| Breath Tests | 2 | 2009 | 38 | 0.380 |
Why?
| Environmental Exposure | 1 | 2012 | 201 | 0.370 |
Why?
| Female | 25 | 2024 | 26576 | 0.360 |
Why?
| DNA Damage | 5 | 2025 | 298 | 0.340 |
Why?
| Antineoplastic Agents | 4 | 2024 | 1175 | 0.330 |
Why?
| Hot Temperature | 1 | 2009 | 204 | 0.320 |
Why?
| Rats | 12 | 2013 | 3273 | 0.310 |
Why?
| Exhalation | 1 | 2008 | 19 | 0.300 |
Why?
| Proteomics | 1 | 2009 | 292 | 0.280 |
Why?
| Male | 21 | 2024 | 25454 | 0.280 |
Why?
| Nitrosamines | 2 | 2003 | 9 | 0.270 |
Why?
| Isothiocyanates | 2 | 2003 | 17 | 0.260 |
Why?
| Reproducibility of Results | 5 | 2012 | 1182 | 0.250 |
Why?
| Globins | 1 | 2004 | 14 | 0.240 |
Why?
| Focal Adhesion Kinase 2 | 1 | 2024 | 17 | 0.240 |
Why?
| Stereoisomerism | 3 | 2020 | 101 | 0.230 |
Why?
| Styrene | 3 | 2013 | 9 | 0.230 |
Why?
| Oligodendroglioma | 1 | 2023 | 6 | 0.220 |
Why?
| Dose-Response Relationship, Drug | 3 | 2021 | 1354 | 0.220 |
Why?
| Cell Line | 3 | 2021 | 1010 | 0.220 |
Why?
| Astrocytoma | 1 | 2023 | 19 | 0.220 |
Why?
| Osteoporosis | 1 | 2024 | 155 | 0.210 |
Why?
| Kinetics | 7 | 2021 | 632 | 0.210 |
Why?
| Glucuronosyltransferase | 2 | 2014 | 122 | 0.210 |
Why?
| Cross-Linking Reagents | 3 | 2008 | 43 | 0.210 |
Why?
| Glioma | 1 | 2023 | 76 | 0.210 |
Why?
| Cell Survival | 1 | 2024 | 590 | 0.210 |
Why?
| Glucocorticoids | 1 | 2024 | 229 | 0.210 |
Why?
| Genotype | 3 | 2020 | 539 | 0.200 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 155 | 0.200 |
Why?
| Rats, Inbred F344 | 6 | 2013 | 196 | 0.190 |
Why?
| Aryl Hydrocarbon Hydroxylases | 2 | 2012 | 74 | 0.190 |
Why?
| Phenotype | 2 | 2021 | 728 | 0.190 |
Why?
| Meclofenamic Acid | 1 | 2020 | 2 | 0.190 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2021 | 24 | 0.180 |
Why?
| Sensitivity and Specificity | 4 | 2011 | 858 | 0.180 |
Why?
| Surface Properties | 1 | 2020 | 72 | 0.180 |
Why?
| Lipid Metabolism | 1 | 2021 | 175 | 0.180 |
Why?
| Adamantane | 1 | 2020 | 24 | 0.180 |
Why?
| Indazoles | 1 | 2020 | 44 | 0.180 |
Why?
| Particle Size | 1 | 2020 | 79 | 0.180 |
Why?
| Cell Proliferation | 1 | 2024 | 986 | 0.180 |
Why?
| Metabolic Networks and Pathways | 1 | 2020 | 90 | 0.180 |
Why?
| Plasmids | 1 | 2020 | 164 | 0.170 |
Why?
| Brain Neoplasms | 1 | 2023 | 282 | 0.170 |
Why?
| Proteins | 1 | 2003 | 347 | 0.170 |
Why?
| Nucleic Acid Conformation | 3 | 2011 | 85 | 0.170 |
Why?
| Substrate Specificity | 3 | 2021 | 192 | 0.170 |
Why?
| Inhalation Exposure | 4 | 2010 | 30 | 0.170 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 168 | 0.170 |
Why?
| Transplantation, Homologous | 1 | 2019 | 140 | 0.170 |
Why?
| Models, Molecular | 3 | 2019 | 334 | 0.170 |
Why?
| Leukemia | 1 | 2019 | 64 | 0.160 |
Why?
| Paraventricular Hypothalamic Nucleus | 1 | 2019 | 8 | 0.160 |
Why?
| Computational Biology | 1 | 2021 | 214 | 0.160 |
Why?
| Cannabinoids | 1 | 2020 | 103 | 0.160 |
Why?
| Lymphoma | 1 | 2019 | 65 | 0.160 |
Why?
| Software | 1 | 2021 | 273 | 0.160 |
Why?
| Organoplatinum Compounds | 3 | 2011 | 15 | 0.160 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 40 | 0.160 |
Why?
| Stem Cell Transplantation | 1 | 2019 | 179 | 0.160 |
Why?
| Hypoxanthine Phosphoribosyltransferase | 4 | 2011 | 21 | 0.160 |
Why?
| Middle Aged | 5 | 2019 | 12293 | 0.150 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2019 | 212 | 0.150 |
Why?
| Adenosine | 2 | 2009 | 70 | 0.150 |
Why?
| Repressor Proteins | 1 | 2019 | 149 | 0.150 |
Why?
| Kynurenine | 1 | 2017 | 14 | 0.150 |
Why?
| Glutathione Disulfide | 1 | 2017 | 40 | 0.150 |
Why?
| Aged | 4 | 2019 | 9449 | 0.150 |
Why?
| Computer Simulation | 1 | 2018 | 281 | 0.140 |
Why?
| Models, Biological | 2 | 2018 | 719 | 0.140 |
Why?
| Electron Transport Complex III | 1 | 2017 | 6 | 0.140 |
Why?
| Inhibitory Concentration 50 | 2 | 2014 | 71 | 0.140 |
Why?
| Succinate Dehydrogenase | 1 | 2017 | 22 | 0.140 |
Why?
| Young Adult | 3 | 2019 | 4031 | 0.140 |
Why?
| Electron Transport Complex IV | 1 | 2017 | 28 | 0.140 |
Why?
| Mice, Inbred C57BL | 4 | 2024 | 1777 | 0.140 |
Why?
| Electron Transport Complex I | 1 | 2017 | 22 | 0.140 |
Why?
| Biopsy, Needle | 1 | 2017 | 182 | 0.140 |
Why?
| Reactive Oxygen Species | 2 | 2017 | 405 | 0.140 |
Why?
| Diet, High-Fat | 1 | 2019 | 214 | 0.140 |
Why?
| Adult | 6 | 2019 | 13356 | 0.140 |
Why?
| Sex Characteristics | 3 | 2006 | 191 | 0.140 |
Why?
| DNA Copy Number Variations | 1 | 2017 | 108 | 0.130 |
Why?
| Nitrophenols | 2 | 2013 | 17 | 0.130 |
Why?
| Sulfides | 1 | 2016 | 28 | 0.130 |
Why?
| X-Rays | 1 | 2016 | 55 | 0.130 |
Why?
| Cystic Fibrosis | 2 | 2009 | 151 | 0.130 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 110 | 0.130 |
Why?
| Glucose | 2 | 2008 | 337 | 0.130 |
Why?
| Neurons | 1 | 2019 | 455 | 0.130 |
Why?
| Neoplasm Staging | 1 | 2017 | 749 | 0.120 |
Why?
| Amino Acid Sequence | 2 | 2007 | 579 | 0.120 |
Why?
| Hazardous Substances | 1 | 2014 | 15 | 0.110 |
Why?
| Reference Standards | 2 | 2011 | 52 | 0.110 |
Why?
| Calibration | 2 | 2011 | 57 | 0.110 |
Why?
| Aromatase Inhibitors | 1 | 2013 | 14 | 0.110 |
Why?
| Nitriles | 1 | 2013 | 52 | 0.110 |
Why?
| Gas Chromatography-Mass Spectrometry | 2 | 2003 | 66 | 0.100 |
Why?
| Methylmalonyl-CoA Decarboxylase | 1 | 2012 | 5 | 0.100 |
Why?
| Carbon-Carbon Ligases | 1 | 2012 | 7 | 0.100 |
Why?
| Glutarates | 1 | 2012 | 6 | 0.100 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2012 | 13 | 0.100 |
Why?
| Carbon-Nitrogen Ligases | 1 | 2012 | 14 | 0.100 |
Why?
| Triazoles | 1 | 2013 | 112 | 0.100 |
Why?
| Aged, 80 and over | 2 | 2017 | 3138 | 0.100 |
Why?
| Lipid Peroxidation | 2 | 2009 | 96 | 0.100 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 178 | 0.100 |
Why?
| Platinum | 1 | 2011 | 11 | 0.100 |
Why?
| Pentanes | 1 | 2011 | 2 | 0.100 |
Why?
| Adenosine Monophosphate | 2 | 2009 | 15 | 0.100 |
Why?
| Deoxyadenosines | 1 | 2011 | 5 | 0.100 |
Why?
| Base Pairing | 1 | 2011 | 27 | 0.100 |
Why?
| Hemiterpenes | 1 | 2011 | 10 | 0.100 |
Why?
| Erythrocytes | 1 | 2011 | 83 | 0.100 |
Why?
| Creatinine | 1 | 2011 | 140 | 0.090 |
Why?
| Urea | 2 | 2009 | 77 | 0.090 |
Why?
| Leucine | 1 | 2011 | 115 | 0.090 |
Why?
| Outpatients | 1 | 2011 | 112 | 0.090 |
Why?
| Cost-Benefit Analysis | 1 | 2011 | 269 | 0.090 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 483 | 0.090 |
Why?
| Freezing | 1 | 2009 | 16 | 0.090 |
Why?
| Comet Assay | 1 | 2009 | 9 | 0.090 |
Why?
| F2-Isoprostanes | 1 | 2009 | 8 | 0.090 |
Why?
| Molecular Sequence Data | 2 | 2011 | 799 | 0.080 |
Why?
| Hydantoins | 1 | 2009 | 2 | 0.080 |
Why?
| Ribonucleosides | 1 | 2009 | 2 | 0.080 |
Why?
| Chlorobenzoates | 1 | 2009 | 2 | 0.080 |
Why?
| Risk Assessment | 3 | 2010 | 1255 | 0.080 |
Why?
| Hydrogen Peroxide | 1 | 2009 | 114 | 0.080 |
Why?
| Half-Life | 1 | 2009 | 85 | 0.080 |
Why?
| Oxidants | 1 | 2009 | 54 | 0.080 |
Why?
| Species Specificity | 4 | 2013 | 193 | 0.080 |
Why?
| Oxidation-Reduction | 4 | 2013 | 315 | 0.080 |
Why?
| HeLa Cells | 1 | 2009 | 257 | 0.080 |
Why?
| Lymphocytes | 1 | 2009 | 154 | 0.080 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 2011 | 244 | 0.080 |
Why?
| Dwarfism, Pituitary | 1 | 2008 | 4 | 0.080 |
Why?
| Trichloroethylene | 1 | 2009 | 64 | 0.080 |
Why?
| Carboplatin | 2 | 2024 | 51 | 0.080 |
Why?
| Formaldehyde | 1 | 2008 | 50 | 0.080 |
Why?
| Food Deprivation | 1 | 2007 | 29 | 0.070 |
Why?
| Bronchi | 1 | 2008 | 43 | 0.070 |
Why?
| Toxicology | 1 | 2007 | 29 | 0.070 |
Why?
| Liver | 3 | 2013 | 1106 | 0.070 |
Why?
| Pituitary Gland | 1 | 2008 | 85 | 0.070 |
Why?
| Structural Homology, Protein | 1 | 2007 | 9 | 0.070 |
Why?
| Chemical Industry | 1 | 2006 | 3 | 0.070 |
Why?
| Spiro Compounds | 1 | 2006 | 8 | 0.070 |
Why?
| Imines | 1 | 2006 | 12 | 0.070 |
Why?
| Histones | 1 | 2008 | 295 | 0.070 |
Why?
| Binding Sites | 3 | 2013 | 378 | 0.070 |
Why?
| Ecdysteroids | 1 | 2006 | 1 | 0.070 |
Why?
| Manduca | 1 | 2006 | 2 | 0.070 |
Why?
| Hemolymph | 1 | 2006 | 9 | 0.070 |
Why?
| Aldehydes | 1 | 2006 | 82 | 0.060 |
Why?
| Asthma | 1 | 2009 | 282 | 0.060 |
Why?
| Amides | 1 | 2024 | 36 | 0.060 |
Why?
| Gene Expression Profiling | 2 | 2006 | 1028 | 0.060 |
Why?
| Buthionine Sulfoximine | 1 | 2024 | 13 | 0.060 |
Why?
| T-Lymphocytes | 1 | 2006 | 328 | 0.060 |
Why?
| Rabbits | 1 | 2004 | 375 | 0.060 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 2023 | 8 | 0.060 |
Why?
| Isocitrate Dehydrogenase | 1 | 2023 | 17 | 0.060 |
Why?
| Administration, Oral | 1 | 2024 | 433 | 0.050 |
Why?
| Acetaminophen | 1 | 2006 | 275 | 0.050 |
Why?
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2003 | 10 | 0.050 |
Why?
| Protein Kinase Inhibitors | 1 | 2024 | 205 | 0.050 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2023 | 92 | 0.050 |
Why?
| Formamides | 1 | 2021 | 3 | 0.050 |
Why?
| Prospective Studies | 1 | 2008 | 2345 | 0.050 |
Why?
| Furans | 1 | 2021 | 26 | 0.050 |
Why?
| Drug Resistance, Neoplasm | 1 | 2024 | 314 | 0.050 |
Why?
| Mice, Inbred Strains | 2 | 2013 | 160 | 0.050 |
Why?
| Halogenation | 1 | 2021 | 4 | 0.050 |
Why?
| Quinones | 1 | 2021 | 8 | 0.050 |
Why?
| Acetic Acid | 1 | 2021 | 12 | 0.050 |
Why?
| Aging | 1 | 2006 | 669 | 0.050 |
Why?
| Propionates | 1 | 2021 | 22 | 0.050 |
Why?
| Cohort Studies | 2 | 2018 | 1403 | 0.050 |
Why?
| Templates, Genetic | 1 | 2021 | 14 | 0.050 |
Why?
| RNA, Ribosomal | 1 | 2021 | 20 | 0.050 |
Why?
| Biological Availability | 1 | 2021 | 99 | 0.050 |
Why?
| Methyltransferases | 1 | 2021 | 29 | 0.050 |
Why?
| Adenine | 1 | 2021 | 31 | 0.050 |
Why?
| RNA, Fungal | 1 | 2021 | 21 | 0.050 |
Why?
| Nucleotide Motifs | 1 | 2021 | 23 | 0.050 |
Why?
| Benzoquinones | 1 | 2020 | 29 | 0.050 |
Why?
| RNA, Bacterial | 1 | 2021 | 58 | 0.050 |
Why?
| Bone and Bones | 1 | 2024 | 473 | 0.050 |
Why?
| Spectrometry, Fluorescence | 1 | 2020 | 47 | 0.050 |
Why?
| Models, Chemical | 1 | 2020 | 64 | 0.050 |
Why?
| Meiosis | 1 | 2021 | 65 | 0.040 |
Why?
| Pyrimidines | 1 | 2021 | 192 | 0.040 |
Why?
| ROC Curve | 1 | 2021 | 225 | 0.040 |
Why?
| Recombinant Proteins | 2 | 2012 | 482 | 0.040 |
Why?
| Sequence Analysis, DNA | 1 | 2021 | 237 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 2021 | 178 | 0.040 |
Why?
| Escherichia coli | 1 | 2021 | 191 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2021 | 370 | 0.040 |
Why?
| Biocatalysis | 1 | 2019 | 14 | 0.040 |
Why?
| Pro-Opiomelanocortin | 1 | 2019 | 9 | 0.040 |
Why?
| Child | 2 | 2009 | 6849 | 0.040 |
Why?
| Protein Binding | 2 | 2012 | 656 | 0.040 |
Why?
| Mice, Knockout | 1 | 2021 | 835 | 0.040 |
Why?
| Databases, Factual | 1 | 2021 | 660 | 0.040 |
Why?
| Cattle | 2 | 2009 | 207 | 0.040 |
Why?
| Protons | 2 | 2011 | 67 | 0.040 |
Why?
| Temperature | 2 | 2011 | 163 | 0.040 |
Why?
| RNA, Messenger | 1 | 2021 | 1099 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2018 | 394 | 0.040 |
Why?
| Pilot Projects | 1 | 2018 | 702 | 0.030 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2007 | 30 | 0.030 |
Why?
| Antifungal Agents | 1 | 2018 | 343 | 0.030 |
Why?
| Acyl Coenzyme A | 1 | 2014 | 8 | 0.030 |
Why?
| False Negative Reactions | 1 | 2014 | 29 | 0.030 |
Why?
| Hep G2 Cells | 1 | 2014 | 36 | 0.030 |
Why?
| Culture Media | 1 | 2014 | 94 | 0.030 |
Why?
| Sapogenins | 1 | 2013 | 4 | 0.030 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 35 | 0.030 |
Why?
| Triazines | 1 | 2013 | 24 | 0.030 |
Why?
| Allosteric Regulation | 1 | 2012 | 13 | 0.030 |
Why?
| Pharmacogenetics | 1 | 2012 | 51 | 0.030 |
Why?
| Anticonvulsants | 1 | 2013 | 121 | 0.020 |
Why?
| Solutions | 1 | 2011 | 24 | 0.020 |
Why?
| Hydrogen Bonding | 1 | 2011 | 31 | 0.020 |
Why?
| Amines | 1 | 2011 | 39 | 0.020 |
Why?
| Molecular Dynamics Simulation | 1 | 2011 | 34 | 0.020 |
Why?
| Pyrazoles | 1 | 2012 | 111 | 0.020 |
Why?
| Isomerism | 1 | 2010 | 22 | 0.020 |
Why?
| Hydroxylation | 1 | 2010 | 61 | 0.020 |
Why?
| Biotransformation | 1 | 2010 | 84 | 0.020 |
Why?
| Drug Monitoring | 1 | 2011 | 78 | 0.020 |
Why?
| Obesity | 1 | 2019 | 1096 | 0.020 |
Why?
| Base Sequence | 1 | 2011 | 657 | 0.020 |
Why?
| DNA-Formamidopyrimidine Glycosylase | 1 | 2009 | 1 | 0.020 |
Why?
| Dichloroacetic Acid | 1 | 2009 | 4 | 0.020 |
Why?
| Trichloroacetic Acid | 1 | 2009 | 8 | 0.020 |
Why?
| Cysteine | 1 | 2009 | 50 | 0.020 |
Why?
| Respiratory Function Tests | 1 | 2009 | 88 | 0.020 |
Why?
| Peptide Mapping | 1 | 2008 | 22 | 0.020 |
Why?
| Chromogranin B | 1 | 2008 | 1 | 0.020 |
Why?
| Secretogranin II | 1 | 2008 | 1 | 0.020 |
Why?
| Adrenocorticotropic Hormone | 1 | 2008 | 31 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2008 | 71 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 63 | 0.020 |
Why?
| Prolactin | 1 | 2008 | 44 | 0.020 |
Why?
| Thyrotropin | 1 | 2008 | 47 | 0.020 |
Why?
| Growth Hormone | 1 | 2008 | 95 | 0.020 |
Why?
| Oleic Acid | 1 | 2007 | 5 | 0.020 |
Why?
| Coumaric Acids | 1 | 2007 | 8 | 0.020 |
Why?
| Longevity | 1 | 2008 | 79 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2008 | 249 | 0.020 |
Why?
| Lysine | 1 | 2008 | 83 | 0.020 |
Why?
| Genes, Reporter | 1 | 2007 | 89 | 0.020 |
Why?
| Glycogenolysis | 1 | 2007 | 10 | 0.020 |
Why?
| Insulin-Like Growth Factor I | 1 | 2008 | 138 | 0.020 |
Why?
| Nucleic Acid Heteroduplexes | 1 | 2007 | 5 | 0.020 |
Why?
| Peptide Fragments | 1 | 2008 | 207 | 0.020 |
Why?
| Pregnancy | 1 | 2014 | 2468 | 0.020 |
Why?
| Immunity, Innate | 1 | 2008 | 104 | 0.020 |
Why?
| Epidemiologic Studies | 1 | 2007 | 25 | 0.020 |
Why?
| Fatty Acids | 1 | 2007 | 143 | 0.020 |
Why?
| Toluene | 1 | 2006 | 5 | 0.020 |
Why?
| Benzene | 1 | 2006 | 6 | 0.020 |
Why?
| Czech Republic | 1 | 2006 | 5 | 0.020 |
Why?
| Sister Chromatid Exchange | 1 | 2006 | 15 | 0.020 |
Why?
| Triglycerides | 1 | 2007 | 152 | 0.020 |
Why?
| Mutagenicity Tests | 1 | 2006 | 41 | 0.020 |
Why?
| Molecular Epidemiology | 1 | 2006 | 39 | 0.020 |
Why?
| Aorta | 1 | 2007 | 162 | 0.020 |
Why?
| Clone Cells | 1 | 2006 | 78 | 0.020 |
Why?
| Mutant Proteins | 1 | 2006 | 37 | 0.020 |
Why?
| Mutagens | 1 | 2006 | 50 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2009 | 907 | 0.020 |
Why?
| Confidence Intervals | 1 | 2006 | 155 | 0.020 |
Why?
| Microchemistry | 1 | 2006 | 5 | 0.020 |
Why?
| Larva | 1 | 2006 | 28 | 0.020 |
Why?
| Acetylcysteine | 1 | 2006 | 103 | 0.020 |
Why?
| Spleen | 1 | 2006 | 170 | 0.020 |
Why?
| Body Composition | 1 | 2007 | 320 | 0.020 |
Why?
| Oxygen | 1 | 2007 | 323 | 0.020 |
Why?
| Chromosome Aberrations | 1 | 2006 | 295 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 2009 | 1576 | 0.010 |
Why?
| Mice, Inbred A | 1 | 2002 | 15 | 0.010 |
Why?
| Time Factors | 1 | 2009 | 2891 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2006 | 1578 | 0.010 |
Why?
| Signal Transduction | 1 | 2009 | 1608 | 0.010 |
Why?
| Drug Interactions | 1 | 2002 | 209 | 0.010 |
Why?
| Child, Preschool | 1 | 2009 | 3879 | 0.010 |
Why?
| Adolescent | 1 | 2009 | 6417 | 0.010 |
Why?
|
|
Boysen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|